Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CHAT Pilot Trial: Rosuvastatin in Critically Ill H1N1 Patients
NCT01033955Phase 2Terminated
- Sponsor
- Canadian Critical Care Trials Group
- Start
- Jan 2010
- Primary completion
- May 2010
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of rosuvastatin in Influenza A H1N1 (H1N1), sponsored by Canadian Critical Care Trials Group. Started Jan 2010; status: terminated.
02
Drugs
rosuvastatin
03
Conditions
Influenza A H1N1 (H1N1)
Beyond the preview
Go deeper on NCT01033955.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01033955.